![](/img/cover-not-exists.png)
Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 Study
Leiter, Lawrence A., Yoon, Kun-Ho, Arias, Pablo, Langslet, Gisle, Xie, John, Balis, Dainius A., Millington, Dawn, Vercruysse, Frank, Canovatchel, William, Meininger, GaryVolume:
38
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc13-2762
Date:
March, 2015
File:
PDF, 1.14 MB
english, 2015